The FDA considers a "Future Framework" that would allow manufacturers like Pfizer and Moderna to release reformulated COVID-19 boosters without new clinical trials, similar to the annual flu shot process. Critics argue this skips essential human data for vaccines targeting new variants like Omicron.
